Plus: averting drug interactions; how patients feel about their tech; Exenatide for type 1?
Can't see the images? View as webpage.
Facebook
Twitter
LinkedIn
To ensure that you never miss an issue, please whitelist us.

May 12, 2020 : DCMS #501

DISASTERS AVERTED — Near Miss Case Studies


Preventing Potential Drug Interaction with a Drug With UNIQUE Directions

TOP STORIES - Diabetes News & Research


Gender Affects Vascular Disease Associated with Diabetes

How Do Patients Prefer to Take their Insulin and Monitor Blood Glucose?

Can Exenatide Improve Glycemic Control In Type 1 Diabetes?
Letter from the Editor

Modern technology has made glucose management much easier for all patients and especially those using insulin. Although we typically think that everyone will like all the data and management tools CGM and pump technology offer, there can be an overload of information that creates undue stress for the patient.

This week in a special feature from our intern Jordan Boyd, PharmD. Candidate Florida Agricultural & Mechanical University School of Pharmacy, we focus on why some patients love the technology and why some don’t, and why it is important to find out how each individual patient feels.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief


Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.

Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.

Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.

Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.

Visit Doctor's Option

DISASTERS AVERTED — Near Miss Case Studies

Preventing Potential Drug Interaction with a Drug With UNIQUE Directions
We were following up with a person with type 2 diabetes who was recently started on the new oral formulation of the GLP-1 receptor agonists semaglutide (Rybelsus®). This patient had a 12-year history of type 2 diabetes as well as several comorbidities....
READ MORE

TOP STORIES - Diabetes News and Research

Gender Affects Vascular Disease Associated with Diabetes
How adipose tissue storage, which differs by gender, plays a role in the development and treatment of the disease. 
READ MORE
How Do Patients Prefer to Take their Insulin and Monitor Blood Glucose?
Are patients on board with new insulin delivery and glucose monitoring technology?
READ MORE
Can Exenatide Improve Glycemic Control In Type 1 Diabetes?
The MAG1C interventional study was a single-center, 26-week, phase 2a, to look at how Exenatide might benefit patients with type 1 diabetes.
READ MORE

MOST POPULAR ARTICLES OF THE MONTH


#1 A1C levels are Indicators of Coronary Atherosclerotic Plaque Formation

#2 Renal Disease Impact On Long-Term Metformin Use

#3 Did You Know? Metformin, along with dozens of drugs, may have promise against COVID-19
 About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com
Facebook
Twitter
LinkedIn
©2020 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of:
Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States


DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe